George Yancopoulos, President Regeneron Laboratori at REGENERON PHARMACEUTICALS INC (REGN), sold 189,463 shares at $318.52 ($60.1M) on 2014-02-12, disclosed to the SEC on 2014-02-13.
Scheduled sale ($60.1M) by President Regeneron Laboratori under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $314.31 | 94,756 | $29.8M | 49.6% |
| 2 | $314.31 | 5,720 | $1.8M | 3.0% |
| 3 | $317.82 | 4,322 | $1.4M | 2.3% |
| 4 | $318.52 | 15,816 | $5.0M | 8.4% |
| 5 | $319.44 | 30,858 | $9.9M | 16.4% |
| 6 | $320.48 | 17,274 |
| $5.5M |
| 9.2% |
| 7 | $321.48 | 8,021 | $2.6M | 4.3% |
| 8 | $322.34 | 3,874 | $1.2M | 2.1% |
| 9 | $323.42 | 1,490 | $482K | 0.8% |
| 10 | $324.61 | 1,700 | $552K | 0.9% |
| 11 | $325.44 | 1,932 | $629K | 1.0% |
| 12 | $326.36 | 2,100 | $685K | 1.1% |
| 13 | $327.88 | 600 | $197K | 0.3% |
| 14 | $328.50 | 1,000 | $329K | 0.5% |
| Total | $317.14 avg | 189,463 | $60.1M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |